Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma
Authors:
Open Access
- 5 January 2022
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 174, 87-91
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Ultra-high-dose-rate FLASH and Conventional-Dose-Rate Irradiation Differentially Affect Human Acute Lymphoblastic Leukemia and Normal HematopoiesisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- Correction for Montay-Gruel et al., Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen speciesProceedings of the National Academy of Sciences, 2020
- Neuroprotection of Radiosensitive Juvenile Mice by Ultra-High Dose Rate FLASH IrradiationCancers, 2020
- Treatment of a first patient with FLASH-radiotherapyRadiotherapy and Oncology, 2019
- Clinical translation of FLASH radiotherapy: Why and how?Radiotherapy and Oncology, 2019
- The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer PatientsClinical Cancer Research, 2019
- High dose‐per‐pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical useMedical Physics, 2017
- Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/sRadiotherapy and Oncology, 2017
- High dose‐per‐pulse electron beam dosimetry: Usability and dose‐rate independence of EBT3 Gafchromic filmsMedical Physics, 2017
- Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in miceScience Translational Medicine, 2014